IDYA as of Oct 31 · 15:17 ET

IDYANasdaqPharmaceutical Preparations

IDEAYA Biosciences, Inc. · Brief

Next report

3 days

Nov 3 · before openest.Q3 FY26

Earnings

Expected move

Inputs

±7.3%implied · report alone

29.6234.30

straddle ±10.8%

spot 31.96exp Nov 20ATM strike 32.5ATM straddle 4.08IV 66%

Oct 30 closereport share · term structurethin chain

Expected move

Inputs

Implied vs realized

8 reportsHistory

1 of 8≥ implied

avg implied: ±11.7%
avg realized: ±4.2%

Nov 4 '24±12.0%▲+4.90%×0.41

Feb 13 '25±18.7%▼−5.42%×0.29

May 6 '25±6.5%▼−13.29%×2.04

Aug 5 '25±16.6%▼−3.52%×0.21

Nov 4 '25±9.7%▼−2.81%×0.29

Feb 17 '26±15.4%▲+1.62%×0.11

Q1 FY26±7.8%▼−0.35%×0.05

Q2 FY26±6.7%▲+2.01%×0.30

quarterimplied−20%0+20%realized×

Q2 FY26±6.7%▲+2.01%×0.30

Q1 FY26±7.8%▼−0.35%×0.05

Feb '26±15.4%▲+1.62%×0.11

Nov '25±9.7%▼−2.81%×0.29

Aug '25±16.6%▼−3.52%×0.21

May '25±6.5%▼−13.29%×2.04

2 older reports

Feb '25±18.7%▼−5.42%×0.29

Nov '24±12.0%▲+4.90%×0.41

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull2

4tracked funds holding IDYAN-PORT · Aug 31 '26

+8.97%ten largest reporting managers increased shares held over the latest quarter13F · Jun 30 '26

Bear2 of 3

9 of 23largest reporting managers reduced their stakes in the latest quarter13F · Jun 30 '26

28managers whose positions together make up most of the reported value13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

IDYA report session

Suppliers 2

GILDGilead×0.14 PFEPfizer×0.12

× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes

Oct 21impliedImplied move: ±14.9% into Nov 3 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.